Advanced search
Start date
Betweenand


Metabolite variations in the sera of HIV plus patients after an oral administration of effervescent glutamine and in comparison to non-HIV individuals by NMR

Full text
Author(s):
Martins, Lucas Gelain ; Fregonesi, Natalia ; Bazotte, Roberto Barbosa ; Laguila Visentainer, Jeane Eliete ; Tasic, Ljubica
Total Authors: 5
Document type: Journal article
Source: MOLECULAR OMICS; v. 19, n. 1, p. 9-pg., 2022-09-10.
Abstract

It was demonstrated that effervescent glutamine supplementation in HIV+ individuals treated with antiretroviral therapy (ART) increased CD4+ T lymphocytes, decreased inflammation biomarkers, and brought health benefits. This pilot study aimed to explore serum metabolite variations in the HIV+ group under ART after 30 days of supplementation with glutamine, and in comparison to the matched HIV- group. The group of HIV+ showed lower levels of choline, creatine, pyruvate, glutamate, lysine, and tyrosine when compared to the HIV- group. Glucose, lipids, lactate, glutamine, phenylalanine, threonine, and phenylalanine/tyrosine were higher in HIV+ patients under long ART. Serum metabolome variations were shown to be consistent with the health improvements observed in the HIV+ group after effervescent glutamine supplementation, which might aid in ART in HIV+ individuals. (AU)

FAPESP's process: 18/24069-3 - ReSEARCH: Recognizing Signatures of the Exposome to Anticipate the Risks for a Continuous Health
Grantee:Fernando Barbosa Júnior
Support Opportunities: Research Projects - Thematic Grants
FAPESP's process: 18/06510-4 - Application of Nuclear Magnetic Resonance (NMR) in metabolomics and metabonomics of human diseases
Grantee:Ljubica Tasic
Support Opportunities: Regular Research Grants